The Combination of Endometrial Injury and Freeze All Strategy in Women With a History of RIF

October 23, 2020 updated by: IOANNIS RIGOS, National and Kapodistrian University of Athens

The Combination of Endometrial Injury and Freeze All Strategy in Women With a History of Repeated Implantation Failure.

The investigators checked the hypothesis whether endometrial injury performed during the cycle before a frozen embryo transfer in women with RIF can improve pregnancy rates

Study Overview

Detailed Description

After a freeze all cycle, participants were divided in two groups: an intervention group (n=30), who underwent endometrial injury before the transfer, and a control group (n=30), who underwent no other intervention. The primary outcome was clinical pregnancy rate, while secondary clinical and laboratory parameters. Baseline and cycle characteristics were also compared between groups.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Athens, Greece
        • National and Kapodistrian University of Athens

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 42 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women with RIF under 42 years old
  • BMI 20-30
  • Normal endometrial cavity
  • FSH <15 IU/L
  • Absence of immunological or hematological disorder

Exclusion Criteria:

  • women over 42 years old
  • FSH>15 IU/L
  • women with chronic immunological or hematological disorder
  • stage III or IV of endometriosis
  • women with pathology concerning the endometrial cavity
  • women with a medical history of adnexectomy or oophorectomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Endometrial injury
Endometrial injury before the embryo transfer of a frozen cycle
Endometrial injury was performed hysteroscopically after freeze all cycles and during the cycle before the frozen embryo transfer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physiological parameter - Live birth rate
Time Frame: 22 weeks
The complete expulsion or extraction from a woman of a product of fertilization, after 22 completed weeks of gestational age
22 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physiological parameter -Clinical pregnancy rate
Time Frame: 7 weeks
A pregnancy diagnosed by ultrasonographic visualization of one or more gestational sacs or definitive clinical signs of pregnancy
7 weeks
Adverse event - Miscarriage
Time Frame: 22 weeks
Spontaneous loss of a clinical pregnancy before 22 completed weeks of gestational age
22 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Charalampos Siristatidis, Prof, National and Kapodistrian University of Athens

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 2, 2017

Primary Completion (Actual)

September 2, 2020

Study Completion (Actual)

October 2, 2020

Study Registration Dates

First Submitted

October 16, 2020

First Submitted That Met QC Criteria

October 16, 2020

First Posted (Actual)

October 22, 2020

Study Record Updates

Last Update Posted (Actual)

October 27, 2020

Last Update Submitted That Met QC Criteria

October 23, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1811198218111982

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hysteroscopy

Clinical Trials on Endometrial injury

3
Subscribe